NSE · BLISSGVS
Bliss GVS Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#686
of 5,072 stocks
▲ 111W
Peak #686 · 27 Sep 2026
Bliss GVS Pharma Limited, a midcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is growing revenue at a solid clip, and posts a modest return on equity.
Market Cap
7,473.77 Cr
P/E Ratio
57.62
P/B Ratio
6.05
ROE
10.94%
ROCE
16.24%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 285.58 Cr | 256.99 Cr | 218.25 Cr | 244.40 Cr |
| Net Profit | 51.37 Cr | 37.00 Cr | 24.78 Cr | 28.59 Cr |
| EPS | 4.73 | 3.37 | 2.20 | 2.58 |
| Operating Profit | 76.06 Cr | 46.93 Cr | 44.90 Cr | 43.67 Cr |
Shareholding pattern
Promoter
35.01%
Public
64.99%
Mutual fund holdings
₹0.13
Cr total
2
Schemes
2
Fund Houses
₹0.13 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.08 Cr (65.0%)
Bandhan Mutual Fund₹0.05 Cr (35.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 08 Jul 2026 | Dividend | Dividend - Re 1 Per Share |
| 18 Feb 2026 | Dividend | Interim Dividend - Re 0.50 Per Share |
| 24 Jul 2025 | Dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share |
| 18 Jul 2024 | Dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share |
| 12 Jul 2023 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.